These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25171732)

  • 1. Differential characteristics of cytotoxic T lymphocytes restricted by the protective HLA alleles B*27 and B*57 in HIV-1 infection.
    Schellens IM; Spits HB; Navis M; Westerlaken GH; Nanlohy NM; Coffeng LE; Kootstra N; Miedema F; Schuitemaker H; Borghans JA; van Baarle D
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):236-45. PubMed ID: 25171732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic.
    Schellens IM; Navis M; van Deutekom HW; Boeser-Nunnink B; Berkhout B; Kootstra N; Miedema F; Keşmir C; Schuitemaker H; van Baarle D; Borghans JA
    AIDS; 2011 Sep; 25(14):1691-700. PubMed ID: 21681058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
    Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
    Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles.
    Day CL; Shea AK; Altfeld MA; Olson DP; Buchbinder SP; Hecht FM; Rosenberg ES; Walker BD; Kalams SA
    J Virol; 2001 Jul; 75(14):6279-91. PubMed ID: 11413294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.
    Bihl F; Frahm N; Di Giammarino L; Sidney J; John M; Yusim K; Woodberry T; Sango K; Hewitt HS; Henry L; Linde CH; Chisholm JV; Zaman TM; Pae E; Mallal S; Walker BD; Sette A; Korber BT; Heckerman D; Brander C
    J Immunol; 2006 Apr; 176(7):4094-101. PubMed ID: 16547245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of available CTL epitopes that induction of cell-mediated immune response against HIV-1 Koran clade B strain using computational technology.
    Park H; Chung YS; Yoon CH; Lee SH; Kim SS; Kang C; Choi BS
    HIV Med; 2016 Jun; 17(6):460-6. PubMed ID: 26471354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.
    Rajapaksa US; Li D; Peng YC; McMichael AJ; Dong T; Xu XN
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13353-8. PubMed ID: 22826228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
    Goulder PJ; Bunce M; Krausa P; McIntyre K; Crowley S; Morgan B; Edwards A; Giangrande P; Phillips RE; McMichael AJ
    AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1691-8. PubMed ID: 8959245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
    Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype.
    Leslie A; Price DA; Mkhize P; Bishop K; Rathod A; Day C; Crawford H; Honeyborne I; Asher TE; Luzzi G; Edwards A; Rousseau CM; Mullins JI; Tudor-Williams G; Novelli V; Brander C; Douek DC; Kiepiela P; Walker BD; Goulder PJ
    J Immunol; 2006 Oct; 177(7):4699-708. PubMed ID: 16982909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
    Ikeda-Moore Y; Tomiyama H; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 Dec; 159(12):6242-52. PubMed ID: 9550428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
    Willberg CB; Garrison KE; Jones RB; Meiklejohn DA; Spotts G; Liegler TJ; Ostrowski MA; Karlsson AC; Hecht FM; Nixon DF
    PLoS One; 2010 Apr; 5(4):e10249. PubMed ID: 20422053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.